Knockdown of astrocyte elevated gene-1 (AEG-1) in cervical cancer cells decreases their invasiveness, epithelial to mesenchymal transition, and chemoresistance

Cell Cycle

Volumn 13, Issue 11, 2014, Pages 1702-1707

  Liu, Xiangwen ^a   Wang, Degui ^a   Liu, Huiling ^b   Feng, Ying ^a   Zhu, Tianyuan ^c   Zhang, Lang ^a   Zhu, Bingdong ^a   Zhang, Ying ^a,d  

^a LANZHOU UNIVERSITY   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

^c Lanzhou Maternal and Child Health Care Hospital   (China)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

AEG 1; Astrocyte elevated gene 1; Cervical cancer; Chemoresistance; Epithelial to mesenchymal transition; Invasiveness; Metastasis

Indexed keywords

CISPLATIN; NERVE CELL ADHESION MOLECULE; PACLITAXEL; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VIMENTIN; CADHERIN; CELL ADHESION MOLECULE; MTDH PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ARTICLE; ASTROCYTE; ASTROCYTE ELEVATED GENE 1; CANCER RESISTANCE; CELL MIGRATION; CELL MOTILITY; CELL VIABILITY; CERVICAL CANCER CELL LINE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; TUMOR INVASION; UPREGULATION; UTERINE CERVIX CANCER; VECTOR CONTROL; DRUG RESISTANCE; DRUG SCREENING; FEMALE; GENETICS; HELA CELL LINE; METABOLISM; RNA INTERFERENCE; UTERINE CERVIX TUMOR; WESTERN BLOTTING;

BLOTTING, WESTERN; CADHERINS; CELL ADHESION MOLECULES; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; RNA INTERFERENCE; TRANSCRIPTION FACTORS; TUMOR STEM CELL ASSAY; UTERINE CERVICAL NEOPLASMS; VIMENTIN;

EID: 84901849503     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.28607     Document Type: Article

References (42)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108; PMID:15761078; http://dx.doi.org/10.3322/ canjclin.55.2.74
2. Castellsagué X, Bosch FX, Muñoz N. Environmental co-factors in HPV carcinogenesis. Virus Res 2002; 89:191-9; PMID:12445659; http://dx.doi.org/10.1016/S0168-1702(02)00188-0
3. Kim CJ, Jeong JK, Park M, Park TS, Park TC, Namkoong SE, Park JS. HPV oligonucleotide micro-array-based detection of HPV genotypes in cervical neoplastic lesions. Gynecol Oncol 2003; 89:210-7; PMID:12713982; http://dx.doi.org/10.1016/S0090-8258(02)00069-0
4. Britt DE, Yang DF, Yang DQ, Flanagan D, Callanan H, Lim YP, Lin SH, Hixson DC. Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells. Exp Cell Res 2004; 300:134-48; PMID:15383321; http://dx.doi.org/10.1016/j.yexcr.2004.06.026
5. Brown DM, Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 2004; 5:365-74; PMID:15093543; http://dx.doi.org/10.1016/S1535-6108(04)00079-0
6. Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky DJ, Fisher PB. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 2005; 353:8-15; PMID:15927426; http://dx.doi.org/10.1016/j.gene.2005.04.006
7. Li J, Zhang N, Song LB, Liao WT, Jiang LL, Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS, et al. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 2008; 14:3319-26; PMID:18519759; http://dx.doi.org/10.1158/1078-0432.CCR-07-4054
8. Zhang B, Liu XX, He JR, Zhou CX, Guo M, He M, Li MF, Chen GQ, Zhao Q. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis 2011; 32:2-9; PMID:20952513; http://dx.doi.org/10.1093/carcin/bgq209
9. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, Place RF, Pookot D, Majid S, Igawa M, et al. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 2007; 26:7647-55; PMID:17563745; http://dx.doi.org/10.1038/sj.onc. 1210572
10. Emdad L, Sarkar D, Su ZZ, Lee SG, Kang DC, Bruce JN, Volsky DJ, Fisher PB. Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther 2007; 114:155-70; PMID:17397930; http://dx.doi.org/10.1016/j.pharmthera.2007.01.010
11. Yoo BK, Emdad L, Su ZZ, Villanueva A, Chiang DY, Mukhopadhyay ND, Mills AS, Waxman S, Fisher RA, Llovet JM, et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 2009; 119:465-77; PMID:19221438; http://dx.doi.org/10.1172/JCI36460
12. Yu C, Chen K, Zheng H, Guo X, Jia W, Li M, Zeng M, Li J, Song L. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 2009; 30:894-901; PMID:19304953; http://dx.doi.org/10.1093/ carcin/bgp064
13. Song L, Li W, Zhang H, Liao W, Dai T, Yu C, Ding X, Zhang L, Li J. Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. J Pathol 2009; 219:317-26; PMID:19644957; http://dx.doi.org/10.1002/path.2595
14. Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, Li F, Reiss M, Au JL, Haffty BG, Kang Y. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 2009; 15:9-20; PMID:19111877; http://dx.doi.org/10.1016/j.ccr.2008.11.013
15. Liu H, Song X, Liu C, Xie L, Wei L, Sun R. Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells. J Exp Clin Cancer Res 2009; 28:19; PMID:19216799; http://dx.doi.org/10.1186/1756-9966-28-19
16. Emdad L, Lee SG, Su ZZ, Jeon HY, Boukerche H, Sarkar D, Fisher PB. Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc Natl Acad Sci U S A 2009; 106:21300-5; PMID:19940250; http://dx.doi.org/10.1073/pnas.0910936106
17. Liu B, Wu Y, Peng D. Astrocyte elevated gene-1 regulates osteosarcoma cell invasion and chemoresistance via endothelin-1/endothelin A receptor signaling. Oncol Lett 2013; 5:505-10; PMID:23420812
18. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133:704-15; PMID:18485877; http://dx.doi.org/10.1016/j.cell.2008.03.027
19. Min C, Eddy SF, Sherr DH, Sonenshein GE. NF-kappaB and epithelial to mesenchymal transition of cancer. J Cell Biochem 2008; 104:733-44; PMID:18253935; http://dx.doi.org/10.1002/jcb.21695
20. Hsu YM, Chen YF, Chou CY, Tang MJ, Chen JH, Wilkins RJ, Ellory JC, Shen MR. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition. Cancer Res 2007; 67:11064-73; PMID:18006853; http://dx.doi.org/10.1158/0008-5472.CAN-07-2443
21. Yi JY, Hur KC, Lee E, Jin YJ, Arteaga CL, Son YS. TGFbeta1 -mediated epithelial to mesenchymal transition is accompanied by invasion in the SiHa cell line. Eur J Cell Biol 2002; 81:457-68; PMID:12234017; http://dx.doi.org/10. 1078/0171-9335-00265
22. Veeraraghavalu K, Subbaiah VK, Srivastava S, Chakrabarti O, Syal R, Krishna S. Complementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1-phosphatidylinositol 3-kinase signaling involves pleiotropic oncogenic functions independent of CBF1;Su(H);Lag-1 activation. J Virol 2005; 79:7889-98; PMID:15919944; http://dx.doi.org/10.1128/JVI.79.12.7889- 7898.2005
23. Gumbiner BM. Regulation of cadherin adhesive activity. J Cell Biol 2000; 148:399-404; PMID:10662767; http://dx.doi.org/10.1083/jcb.148.3.399
24. Hao L, Ha JR, Kuzel P, Garcia E, Persad S, Steiniche T. Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail. Br J Dermatol 2012; 166:1184-97; PMID:22332917; http://dx.doi.org/10.1111/j.1365-2133.2012.10824.x
25. Berx G, Staes K, van Hengel J, Molemans F, Bussemakers MJ, van Bokhoven A, van Roy F. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 1995; 26:281-9; PMID:7601454; http://dx.doi.org/10. 1016/0888-7543(95)80212-5
26. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases. J Am Coll Surg 2001; 192:708-18; PMID:11400964; http://dx.doi.org/10.1016/S1072-7515(01)00840-7
27. Hendrix MJ, Seftor EA, Chu YW, Trevor KT, Seftor RE. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev 1996; 15:507-25; PMID:9034607; http://dx.doi.org/10.1007/BF00054016
28. Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD, Chodosh LA. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 2005; 8:197-209; PMID:16169465; http://dx.doi.org/10.1016/j.ccr.2005.07.009
29. Wu Y, Zhou BP. New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai) 2008; 40:643-50; PMID:18604456; http://dx.doi.org/10.1111/j.1745-7270.2008.00443.x
30. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005; 132:3151-61; PMID:15983400; http://dx.doi.org/10.1242/dev.01907
31. Guarino M. Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol 2007; 39:2153-60; PMID:17825600; http://dx.doi.org/10.1016/j. biocel.2007.07.011
32. Huber MA, Azoitei N, Baumann B, Grünert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 2004; 114:569-81; PMID:15314694; http://dx.doi.org/10.1172/JCI200421358
33. Liu HY, Liu CX, Han B, Zhang XY, Sun RP. AEG-1 is associated with clinical outcome in neuroblastoma patients. Cancer Biomark 2012; 11:115-21; PMID:23011158
34. Kwon MJ. Emerging roles of claudins in human cancer. Int J Mol Sci 2013; 14:18148-80; PMID:24009024; http://dx.doi.org/10.3390/ijms140918148
35. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010; 29:4741-51; PMID:20531305; http://dx.doi.org/10.1038/onc.2010.215
36. Meng X, Brachova P, Yang S, Xiong Z, Zhang Y, Thiel KW, Leslie KK. Knockdown of MTDH sensitizes endometrial cancer cells to cell death induction by death receptor ligand TRAIL and HDAC inhibitor LBH589 co-treatment. PLoS One 2011; 6:e20920; PMID:21687633; http://dx.doi.org/10.1371/journal.pone.0020920
37. Zhou J, Zhang H, Gu P, Bai J, Margolick JB, Zhang Y. NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells. Breast Cancer Res Treat 2008; 111:419-27; PMID:17965935; http://dx.doi.org/10.1007/s10549-007- 9798-y
38. Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007; 23:675-99; PMID:17645413; http://dx.doi.org/10. 1146/annurev.cellbio.22.010305.104154
39. Zhou J, Zhang Y. Cancer stem cells: Models, mechanisms and implications for improved treatment. Cell Cycle 2008; 7:1360-70; PMID:18418062; http://dx.doi.org/10.4161/cc.7.10.5953
40. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007; 2:329-33; PMID:17406593; http://dx.doi.org/10.1038/nprot.2007.30
41. Li X, Kong X, Huo Q, Guo H, Yan S, Yuan C, Moran MS, Shao C, Yang Q. Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. Cancer Sci 2011; 102:1151-7; PMID:21371176; http://dx.doi.org/10.1111/j.1349-7006.2011.01919.x
42. Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J, Margolick JB, Liotta LA, Petricoin E 3rd, Zhang Y. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A 2007; 104:16158-63; PMID:17911267; http://dx.doi.org/10. 1073/pnas.0702596104